Penserra Capital Management’s Protagonist Therapeutics PTGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-2,429
| Closed | -$117K | – | 1113 |
|
|
2025
Q1 | $117K | Buy |
+2,429
| New | +$117K | ﹤0.01% | 785 |
|
|
2021
Q4 | – | Sell |
-1,090
| Closed | -$19K | – | 1505 |
|
|
2021
Q3 | $19K | Buy |
1,090
+90
| +9% | +$1.57K | ﹤0.01% | 1256 |
|
|
2021
Q2 | $44K | Buy |
1,000
+30
| +3% | +$1.32K | ﹤0.01% | 1035 |
|
|
2021
Q1 | $25K | Buy |
970
+90
| +10% | +$2.32K | ﹤0.01% | 931 |
|
|
2020
Q4 | $17K | Buy |
880
+564
| +178% | +$10.9K | ﹤0.01% | 869 |
|
|
2020
Q3 | $6K | Buy |
+316
| New | +$6K | ﹤0.01% | 855 |
|